Tradestie Institutional Equity Comparison Engine

VTVT vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Momentum & Technical while VTVT counters with relative strength in Options & Structure. Fundamentally, VTVT trades at N/M Forward P/E with -29.8% operating margin (+0.0% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, VTVT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
VTVT N/M vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin -29.8% vs 41.0% ยท YoY +0.0% vs -47.7%
Momentum & Technical Winner CRMD
1Y -43.6% vs -56.2% ยท 52W Pos 1% vs 3%
Options & Structure Winner VTVT
UNCLASSIFIED (N/A IV) vs BREAKDOWN (25th %ile IV)
VTVT NASDAQ
vTv Therapeutics Inc. Class A Common Stock
Pharmaceutical Preparations
$17.62
-10.51% 1D
Market Cap $78.3M
1M Return -33.61%
1Y Return -43.65%
Forward P/E N/M
Unified AI Score
39.2 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 55.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VTVT -43.65% CRMD -56.16% Spread: +12.51 pp (VTVT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VTVT TTM Op. Margin: -29.8% CRMD TTM Op. Margin: 41.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTVT vs CRMD. Trailing 12-month operating profitability (VTVT -29.8% vs CRMD 41.0%) and valuation multiples (VTVT N/M vs CRMD 49.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VTVT (2) vs CRMD (8)
Institutional Metric VTVT CRMD Criterion Row Winner
Market Capitalization Scale $78.3M $384.7M Larger Scale CRMD
Trailing P/E Ratio Valuation N/M 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation N/M 49.0x Lower Multiple CRMD
Revenue Growth (YoY) Growth +0.0% -47.7% Higher Growth VTVT
Operating Margin (TTM) Profitability -29.8% 41.0% Higher Margin CRMD
Net Profit Margin Profitability -20.8% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency -10.9% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 1% ($17โ€“$44) 3% ($5โ€“$13) Stronger Trend CRMD
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 53% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk VTVT
Unified Institutional Score Composite Signal 39.2 / 100 (SELL) 53.2 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VTVT vs CRMD Buy Guide
VTVT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VTVT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VTVT nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.